Global Virus Network

Recent papers from Global Virus Network

1. The NS4B A119T mutation of dengue virus 2 confers adaptation to mammalian cells and increased pathogenicity in AG129 miceJournal of General Virology · 2026
2. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023The Lancet · 2025
3. Integrated in vivo and transcriptomic analyses of lethal Oropouche virus infection reveal suppression of pathogenic host responses by antiviral therapyPLoS Pathogens · 2026
4. Cystatin F as a neuroimmune effector in CNS inflammation and neurodegenerationFrontiers in Cell and Developmental Biology · 2026
5. Factors associated with viral suppression and antiretroviral therapy adherence among adolescents and young adults living with HIV in the African Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes · 2026
6. A Rapid Detection of Nipah Virus Nucleocapsid Antigen in Inactivated Viral CulturesEmerging Microbes & Infections · 2026
7. Dynamics of global mpox epidemics, 1970–2025: a systematic review and meta-analysis of evolving transmissibility and intervention effectsBMJ Global Health · 2026
8. Differential immunogenicity of a live attenuated SARS-CoV-2 vaccine candidate by subcutaneous inoculation in hamsters and nonhuman primates: A cautionary noteVaccine X · 2026
9. Routine immunization uptake and timeliness in young children exposed to multidrug-resistant tuberculosis: A secondary analysis of the Tuberculosis Child Multidrug-Resistant Preventive Therapy multi-site randomised controlled trialBMC Global and Public Health · 2026
10. PHOTObiomodulation for REsistant Depression Study: An Open-Label Pilot Trial on Transcranial Photobiomodulation for Treatment-Resistant DepressionPhotobiomodulation Photomedicine and Laser Surgery · 2026
11. First molecular evidence of reptile‐associated Borrelia spp. in tortoise bont ticks ( Amblyomma marmoreum ) collected in ZambiaMedical and Veterinary Entomology · 2026
12. From Targets to Real World Impact: A Review of Models of Care for Chronic HBV and HCV in EuropeThe Lancet Regional Health - Europe · 2026
13. C93-04 Treatment With Vapendavir After Rhinovirus Challenge in COPD Protects Lung Function and Accelerates Virus Clearance and Symptom Resolution - Results From a Phase 2A Randomised Double-Blind Placebo-Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine · 2026
14. A101-05 WILDCAT: Clinical and Lung Transcriptional Outcomes of a Rhinovirus Challenge Study in Chronic Obstructive Pulmonary Disease PatientsAmerican Journal of Respiratory and Critical Care Medicine · 2026
15. B32-36 IBI3002, A First-in-class Anti-IL-4RΑ/TSLP Bispecific Antibody in Patients With Mild-To-Moderate Asthma: A Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase Ib StudyAmerican Journal of Respiratory and Critical Care Medicine · 2026
16. In Vitro Selection and Characterization of Tecovirimat-resistant Mpox VirusThe Journal of Infectious Diseases · 2026
17. Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategiesMicrobiology and Molecular Biology Reviews · 2026
18. A Molecular and Structural Perspective on Bluetongue Virus Entry and AssemblyPathogens · 2026
19. Burden of 292 causes of death and life expectancy decomposition in Iran, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023The Lancet Global Health · 2026
20. Cross-protection against highly pathogenic avian influenza H5N1 virus from seasonal influenza vaccines: a systematic review and meta-analysis of ferret studiesEmerging Microbes & Infections · 2026